Medicinal product name Febuxostat Mylan
Pharmaceutical form Film-coated tablet
Strength 80 mg 
Information from the MAH on shortages Not available
predicted availability date: Mar 31, 2025
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code M04AA03 Antigout preparations

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: Mar 31, 2025
currently no information on availability from any wholesaler N28
(80 mg)
OPA/Al/PVC/Al blister    EU/1/17/1194/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/17/1194/002
Date of authorisation Jun 15, 2017
Marketing authorisation holder, country Mylan Pharmaceuticals Limited, Ireland